Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice.

Guillerey C, Mouriès J, Polo G, Doyen N, Law HK, Chan S, Kastner P, Leclerc C, Dadaglio G.

Blood. 2012 Jul 5;120(1):90-9. doi: 10.1182/blood-2012-02-410936. Epub 2012 May 18.

2.

NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.

Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, Fischer JA, Weiss S, Kalinke U, Kunz S, Bogdan C.

J Exp Med. 2007 Apr 16;204(4):893-906. Epub 2007 Mar 26.

3.

Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates.

Poth JM, Coch C, Busch N, Boehm O, Schlee M, Janke M, Zillinger T, Schildgen O, Barchet W, Hartmann G.

J Immunol. 2010 Dec 15;185(12):7367-73. doi: 10.4049/jimmunol.1001798. Epub 2010 Nov 5.

4.

Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, Krieg AM, Heppner DG, Stewart VA, Hasegawa H, Looareesuwan S, Shanks GD, Miller RS.

J Immunol. 2004 Apr 15;172(8):4926-33.

5.

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses.

Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A.

Blood. 2006 Dec 1;108(12):3851-8. Epub 2006 Jul 27.

6.

Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC.

Tai LH, Goulet ML, Belanger S, Toyama-Sorimachi N, Fodil-Cornu N, Vidal SM, Troke AD, McVicar DW, Makrigiannis AP.

J Exp Med. 2008 Dec 22;205(13):3187-99. doi: 10.1084/jem.20080718. Epub 2008 Dec 15.

7.

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G.

J Immunol. 2002 May 1;168(9):4531-7.

8.
9.

Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells.

Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP, Söderberg-Nauclér C.

J Immunol. 2007 Dec 1;179(11):7767-76.

10.

Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.

Schroeder JT, Chichester KL, Bieneman AP.

J Allergy Clin Immunol. 2008 Feb;121(2):486-91. Epub 2007 Nov 26.

PMID:
18036648
11.

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd.

J Immunol. 2006 Dec 15;177(12):8701-7.

12.

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.

Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3516-21. Epub 2004 Mar 1.

13.

Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.

Pahl JH, Verhoeven DH, Kwappenberg KM, Vellinga J, Lankester AC, van Tol MJ, Schilham MW.

Mol Immunol. 2012 May;51(1):91-100. doi: 10.1016/j.molimm.2012.02.119. Epub 2012 Mar 16.

PMID:
22424784
14.
15.

Toll-like receptor 9, CpG DNA and innate immunity.

Ashkar AA, Rosenthal KL.

Curr Mol Med. 2002 Sep;2(6):545-56. Review.

PMID:
12243247
16.

TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.

Liese J, Schleicher U, Bogdan C.

Eur J Immunol. 2007 Dec;37(12):3424-34.

17.

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.

Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ.

J Exp Med. 2006 Aug 7;203(8):1999-2008. Epub 2006 Jul 24.

18.

Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.

Mandl JN, Akondy R, Lawson B, Kozyr N, Staprans SI, Ahmed R, Feinberg MB.

J Immunol. 2011 Jun 1;186(11):6406-16. doi: 10.4049/jimmunol.1001191. Epub 2011 Apr 22.

19.

BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.

Jähn PS, Zänker KS, Schmitz J, Dzionek A.

Cell Immunol. 2010;265(1):15-22. doi: 10.1016/j.cellimm.2010.06.005. Epub 2010 Jul 6.

PMID:
20673884
20.

TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells.

Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, McMillan TR, Krieg AM, Akira S, Standiford TJ.

J Immunol. 2007 Sep 15;179(6):3937-46.

Supplemental Content

Support Center